Stocks
Science Applications Financial Statements (SAIC) |
||||||||||
| Science Applicationssmart-lab.ru | % | 2021 | 2022 | 2023 | 2023 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 26.03.2021 | 28.03.2022 | 03.02.2023 | 03.04.2023 | 20.03.2024 | 20.03.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7 056 | 7 394 | 7 704 | 7 704 | 7 444 | 7 153 | |||
| Operating Income, bln rub | 390.0 | 462.0 | 501.0 | 501.0 | 741.0 | 583.0 | ||||
| EBITDA, bln rub | ? | 626.0 | 684.0 | 649.0 | 665.0 | 643.0 | 450.0 | |||
| Net profit, bln rub | ? | 209.0 | 277.0 | 300.0 | 300.0 | 477.0 | 418.0 | |||
| OCF, bln rub | ? | 755.0 | 518.0 | 532.0 | 532.0 | 396.0 | 377.0 | |||
| CAPEX, bln rub | ? | 46.0 | 36.0 | 25.0 | 25.0 | 27.0 | 21.0 | |||
| FCF, bln rub | ? | 709.0 | 482.0 | 507.0 | 507.0 | 369.0 | 356.0 | |||
| Dividend payout, bln rub | 87.0 | 86.0 | 83.0 | 83.0 | 79.0 | 77.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 41.6% | 31.0% | 27.7% | 27.7% | 16.6% | 18.4% | ||||
| OPEX, bln rub | 348.0 | 341.0 | 374.0 | 374.0 | 370.0 | 700.0 | ||||
| Cost of production, bln rub | 6 264 | 6 535 | 6 816 | 6 816 | 6 572 | 6 324 | ||||
| R&D, bln rub | 14.0 | 13.0 | 0.000 | 9.00 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 122.0 | 105.0 | 120.0 | 120.0 | 120.0 | 119.0 | ||||
| Assets, bln rub | 5 723 | 5 746 | 5 543 | 5 543 | 5 314 | 5 314 | ||||
| Net Assets, bln rub | ? | 1 542 | 1 619 | 1 694 | 1 694 | 1 785 | 1 785 | |||
| Debt, bln rub | 2 720 | 2 710 | 2 526 | 2 526 | 2 246 | 2 246 | ||||
| Cash, bln rub | 171.0 | 106.0 | 109.0 | 109.0 | 94.0 | 94.0 | ||||
| Net debt, bln rub | 2 549 | 2 604 | 2 417 | 2 417 | 2 152 | 2 152 | ||||
| Ordinary share price, rub | 96.0 | 81.3 | 104.1 | 104.1 | 129.0 | 114.0 | ||||
| Number of ordinary shares, mln | 58.1 | 57.6 | 55.3 | 55.3 | 53.1 | 52.7 | ||||
| Market cap, bln rub | 5 579 | 4 684 | 5 756 | 5 756 | 6 850 | 6 009 | ||||
| EV, bln rub | ? | 8 128 | 7 288 | 8 173 | 8 173 | 9 002 | 8 161 | |||
| Book value, bln rub | -2 383 | -2 426 | -2 226 | -2 226 | -1 960 | -1 960 | ||||
| EPS, rub | ? | 3.60 | 4.81 | 5.42 | 5.42 | 8.98 | 7.93 | |||
| FCF/share, rub | 12.2 | 8.37 | 9.17 | 9.17 | 6.95 | 6.76 | ||||
| BV/share, rub | -41.0 | -42.1 | -40.3 | -40.3 | -36.9 | -37.2 | ||||
| EBITDA margin, % | ? | 8.87% | 9.25% | 8.42% | 8.63% | 8.64% | 6.29% | |||
| Net margin, % | ? | 2.96% | 3.75% | 3.89% | 3.89% | 6.41% | 5.84% | |||
| FCF yield, % | ? | 12.7% | 10.3% | 8.81% | 8.81% | 5.39% | 5.92% | |||
| ROE, % | ? | 13.6% | 17.1% | 17.7% | 17.7% | 26.7% | 23.4% | |||
| ROA, % | ? | 3.65% | 4.82% | 5.41% | 5.41% | 8.98% | 7.87% | |||
| P/E | ? | 26.7 | 16.9 | 19.2 | 19.2 | 14.4 | 14.4 | |||
| P/FCF | 7.87 | 9.72 | 11.4 | 11.4 | 18.6 | 16.9 | ||||
| P/S | ? | 0.79 | 0.63 | 0.75 | 0.75 | 0.92 | 0.84 | |||
| P/BV | ? | -2.34 | -1.93 | -2.59 | -2.59 | -3.50 | -3.07 | |||
| EV/EBITDA | ? | 13.0 | 10.7 | 12.6 | 12.3 | 14.0 | 18.1 | |||
| Debt/EBITDA | 4.07 | 3.81 | 3.72 | 3.63 | 3.35 | 4.78 | ||||
| R&D/CAPEX, % | 30.4% | 36.1% | 0.00% | 36.0% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.65% | 0.49% | 0.32% | 0.32% | 0.36% | 0.29% | ||||
| Science Applications shareholders | ||||||||||
